I know there are many shareholders who have been w

I know there are many shareholders who have been with Generex far longer than I have been, who have been through good and bad with them, but as for me, what I can say is I have listened to a lot of great things that were supposed to happen with Generex since becoming a shareholder.

I'm still waiting.

I realize things take time. I don't expect things to happen overnight. I don't even expect things to happen necessarily over a week or even a month, depending on what they are. What I do expect though is for companies to not keep pushing out timelines on a regular bases as if it just becomes a standard practice of acceptance. I worked at a company where we had Project Managers and I had many Project Managers that I supervised. If timelines had to be pushed out, there had to be a good reason for it, and there was accountability for missed timelines. Pushing out timelines is never an acceptable practice, yet at Generex, it is the norm.

I am a stickler for Documentation. When you put in Documentation whether it is internal or goes to clients, or government agencies, it is professional, accurate and to the point. It is proof read, then proof read again and followed up on to ensure accuracy and everything is kept up to date. Yet, I see with Generex, this seems not to be done.

I just see a Management team that does not seem to follow through on what it is supposed to be doing. Maybe they are, but appearance iseverything and the appearance in My View, is they appear lost in what they are doing quite a bit of the time.

I hope I am wrong as there is not anything more right now than I want Generex and NGIO to succeed. Everyone has been waiting a long time. Everyone has been hearing so much from Management and have yet to see anything materialize. Let's hope Generex finally pulls it through.

We still have a ways to go until the CCs. A lot can still happen between now and then. A lot is on the table from the Peptides, the funding, the S-1's, the FDA, the products. It's still up to Management how they handle each one and how they deliver the message to their shareholders and possible investors.